1887

Abstract

A murine gammaherpesvirus-68 (MHV-68) mutant with deregulated transcription of its ORF50 transactivator was severely impaired in latency establishment. The deregulated virus showed reduced immunogenicity, probably reflecting a lower antigen load. However, it still elicited effective immunity to a subsequent wild-type (WT) virus challenge. Infection was not completely prevented, but was very substantially reduced in extent and the long-term level of WT viral DNA in lungs and spleens remained low. Thus latency-deficient MHV-68 illustrates a possible general approach to creating attenuated gammaherpesvirus vaccines that can protect against pathogenic WT infections.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19592-0
2004-01-01
2019-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/1/vir850131.html?itemId=/content/journal/jgv/10.1099/vir.0.19592-0&mimeType=html&fmt=ahah

References

  1. Arico, E., Robertson, K., Allen, D., Ferrantini, M., Belardelli, F. & Nash, A. A. ( 2002; ). Humoral immune response and protection from viral infection in mice vaccinated with inactivated MHV-68: effects of type I interferon. J Interferon Cytokine Res 22, 1081–1088.[CrossRef]
    [Google Scholar]
  2. Asano, Y. & Takahashi, M. ( 1977; ). Clinical and serologic testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children. Pediatrics 60, 810–814.
    [Google Scholar]
  3. Binne, U. K., Amon, W. & Farrell, P. J. ( 2002; ). Promoter sequences required for reactivation of Epstein–Barr virus from latency. J Virol 76, 10282–10289.[CrossRef]
    [Google Scholar]
  4. Blasdell, K., McCracken, C., Morris, A., Nash, A. A., Begon, M., Bennett, M. & Stewart, J. P. ( 2003; ). The wood mouse is a natural host for Murid herpesvirus 4. J Gen Virol 84, 111–113.[CrossRef]
    [Google Scholar]
  5. Brooks, J. M., Croom-Carter, D. S., Leese, A. M., Tierney, R. J., Habeshaw, G. & Rickinson, A. B. ( 2000; ). Cytotoxic T-lymphocyte responses to a polymorphic Epstein–Barr virus epitope identify healthy carriers with coresident viral strains. J Virol 74, 1801–1809.[CrossRef]
    [Google Scholar]
  6. Christensen, J. P. & Doherty, P. C. ( 1999; ). Quantitative analysis of the acute and long-term CD4(+) T-cell response to a persistent gammaherpesvirus. J Virol 73, 4279–4283.
    [Google Scholar]
  7. Coleman, H. M., de Lima, B., Morton, V. & Stevenson, P. G. ( 2003; ). Murine gammaherpesvirus 68 lacking thymidine kinase shows severe attenuation of lytic cycle replication in vivo but still establishes latency. J Virol 77, 2410–2417.[CrossRef]
    [Google Scholar]
  8. Doherty, P. C., Tripp, R. A., Hamilton-Easton, A. M., Cardin, R. D., Woodland, D. L. & Blackman, M. A. ( 1997; ). Tuning into immunological dissonance: an experimental model for infectious mononucleosis. Curr Opin Immunol 9, 477–483.[CrossRef]
    [Google Scholar]
  9. Epstein, M. A., Morgan, A. J., Finerty, S., Randle, B. J. & Kirkwood, J. K. ( 1985; ). Protection of cottontop tamarins against Epstein–Barr virus-induced malignant lymphoma by a prototype subunit vaccine. Nature 318, 287–289.[CrossRef]
    [Google Scholar]
  10. Liu, L., Usherwood, E. J., Blackman, M. A. & Woodland, D. L. ( 1999; ). T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice. J Virol 73, 9849–9857.
    [Google Scholar]
  11. May, J. S., Coleman, H. M., Smillie, B., Efstathiou, S. & Stevenson, P. G. ( 2004; ). Forced lytic replication impairs host colonization by a latency-deficient mutant of murine gammaherpesvirus-68. J Gen Virol 85, 137–146.[CrossRef]
    [Google Scholar]
  12. Sitki-Green, D., Covington, M. & Raab-Traub, N. ( 2003; ). Compartmentalization and transmission of multiple Epstein–Barr virus strains in asymptomatic carriers. J Virol 77, 1840–1847.[CrossRef]
    [Google Scholar]
  13. Stevenson, P. G. & Doherty, P. C. ( 1999; ). Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo. J Virol 73, 1075–1079.
    [Google Scholar]
  14. Stevenson, P. G., Belz, G. T., Castrucci, M. R., Altman, J. D. & Doherty, P. C. ( 1999a; ). A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope. Proc Natl Acad Sci U S A 96, 9281–9286.[CrossRef]
    [Google Scholar]
  15. Stevenson, P. G., Cardin, R. D., Christensen, J. P. & Doherty, P. C. ( 1999b; ). Immunological control of a murine gammaherpesvirus independent of CD8+ T cells. J Gen Virol 80, 477–483.
    [Google Scholar]
  16. Stevenson, P. G., Belz, G. T., Altman, J. D. & Doherty, P. C. ( 1999c; ). Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection. Eur J Immunol 29, 1059–1067.[CrossRef]
    [Google Scholar]
  17. Stevenson, P. G., Boname, J. M., de Lima, B. & Efstathiou, S. ( 2002a; ). A battle for survival: immune control and immune evasion in murine gamma-herpesvirus-68 infection. Microbes Infect 4, 1177–1182.[CrossRef]
    [Google Scholar]
  18. Stevenson, P. G., May, J. S., Smith, X. G., Marques, S., Adler, H., Koszinowski, U. H., Simas, J. P. & Efstathiou, S. ( 2002b; ). K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. Nat Immunol 3, 733–740.
    [Google Scholar]
  19. Stewart, J. P., Janjua, N. J., Pepper, S. D., Bennion, G., Mackett, M., Allen, T., Nash, A. A. & Arrand, J. R. ( 1996; ). Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein. J Virol 70, 3528–3535.
    [Google Scholar]
  20. Stewart, J. P., Micali, N., Usherwood, E. J., Bonina, L. & Nash, A. A. ( 1999; ). Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gamma-herpesvirus vaccination. Vaccine 17, 152–157.[CrossRef]
    [Google Scholar]
  21. Sun, R., Lin, S. F., Gradoville, L., Yuan, Y., Zhu, F. & Miller, G. ( 1998; ). A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 95, 10866–10871.[CrossRef]
    [Google Scholar]
  22. Sunil-Chandra, N. P., Arno, J., Fazakerley, J. & Nash, A. A. ( 1994; ). Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68. Am J Pathol 145, 818–826.
    [Google Scholar]
  23. Tibbetts, S. A., McClellan, J. S., Gangappa, S., Speck, S. H. & Virgin, H. W. ( 2003; ). Effective vaccination against long-term gammaherpesvirus latency. J Virol 77, 2522–2529.[CrossRef]
    [Google Scholar]
  24. Usherwood, E. J., Ward, K. A., Blackman, M. A., Stewart, J. P. & Woodland, D. L. ( 2001; ). Latent antigen vaccination in a model gammaherpesvirus infection. J Virol 75, 8283–8288.[CrossRef]
    [Google Scholar]
  25. Walling, D. M., Brown, A. L., Etienne, W., Keitel, W. A. & Ling, P. D. ( 2003; ). Multiple Epstein–Barr virus infections in healthy individuals. J Virol 77, 6546–6550.[CrossRef]
    [Google Scholar]
  26. Wills, M. R., Carmichael, A. J. & Sissons, J. G. ( 2002; ). Vaccines against persistent DNA virus infections. Br Med Bull 62, 125–138.[CrossRef]
    [Google Scholar]
  27. Wu, T. T., Usherwood, E. J., Stewart, J. P., Nash, A. A. & Sun, R. ( 2000; ). Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency. J Virol 74, 3659–3667.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19592-0
Loading
/content/journal/jgv/10.1099/vir.0.19592-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error